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IN 1975 the Department of Pathology established an immunofluorescence labora-
tory to aid diagnosis in dermatology.
The purpose of this paper is to show (1) the use and limitations of the techniques
involved in immunofluorescent procedures, (2) to describe the skin diseases in
which immunofluorescence is of diagnostic or therapeutic value and (3) to review
our experience over the past two years. There are many skin diseases in which
diagnosis can be difficult at a histopathological level, let alone for the clinician.
Immunofluorescence is particularly of value in establishing the diagnosis in the
members of the bullous skin diseases, e.g. pemphigus, pemphigoid, dermatitis
herpetiformis and benign mucous membrane pemphigoid. In classical pemphigus
with a representative, early lesion, the typical features usually are present but
not infrequently the diagnosis can be exceedingly difficult, particularly with old
lesions, and especially if they have become secondarily infected. In such instances
immunofluorescent studies can be crucial to establish the correct diagnosis.
Bullous pemphigoid, dermatitis herpetiformis and benign mucous membrane
pemphigoid have essentially similar microscopic features - they are all typified
by the presence of a sub-epidermal vesicle. Although distinguishing features do
exist, they are not always present and, thus, immunofluorescence can often
resolve the problem. Immunofluorescent studies are essential in patients suffering
from discoid and systemic lupus erythematosus. They are occasionally of value
in establishing the diagnosis of a vasculitis.
TECHNICAL METHODS
Fluorescence occurs when an object is irradiated with light of a particular
(shorter) wavelength and emits light of a longer wavelength. This results in a
colour change. A fluorochrome is a substance which possesses the ability to
fluoresce. A variety of fluorochromes are used, e.g. fluoroscein and rhodamine.
Thus, if one irradiates fluoroscein with blue light it -emits light of an apple-
green colour. To perform immunofluorescence an antibody is 'tagged' with a
fluorochrome. The fluorochrome-labelled antibody may be reactive against
immunoglobulins, complement, or other components. On addition of the fluoro-
chrome-labelled antibody to its appropriate antigen, it becomes fixed. This can
be detected by observing the colour change when the specimen is viewed under
light of the correct wavelength.
195There are essentially two types of test used in an immunofluorescence labora-
tory. One of these is for skin biopsies, the other for examining serum samples.
However, before describing these, it seems appropriate to discuss the method
of taking biopsies, and their transportation.
Ideally, a technician from the laboratory should be present at the time of
taking the biopsy. It is essential that the clinician be aware of the correct site
from which to take the biopsy in each of the various diseases commonly studied
(Fig. 1).
FIG. 1
Suitable sites for biopsy. Stippled line represents the basement membrane region.
4
EPIDERMIS
DERMIS
PEMPHIGUS AND PEMPHIGOID
It is of great importance that biopsies taken from patients with bullous pemphi-
goid and pemphigus include both a portion of a blister (preferably a whole
blister, if this is possible) with adjacent univolved skin. This has the advantage
that both light microscopy and immunofluorescent studies can be performed on
one specimen. In dermatitis herpetiformis the biopsy should be taken from
uninvolved skin adjacent to a lesion and not the lesion itself. If routine histo-
pathological examination is also required, then the biopsy should include both
blister and normal skin, the normal skin being separated and sent for immuno-
fluorescent examination. Immediately after the specimen has been taken from
the patient it should be snap-frozen in an appropriate cooling mixture. A variety
of techniques are available, but we find the use of iso-pentane pre-cooled in
liquid nitrogen satisfactory. Following this the specimen is transferred to a
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k4m4w4ww4m4ww4mmw"w .4M4.40b imcryostat for sectioning. Where laboratory facilities are limited, or when the
technician cannot attend, the specimen may be wrapped in aluminium foil or
parafilm and frozen in liquid nitrogen. The specimen can then be transported
to the laboratory.
Serum samples (without anti-coagulant) can be collected in the usual manner
and submitted to the laboratory.
Skin biopsies are most often examined by the direct immunofluorescent tech-
nique (Fig. 2), the purpose of this being to demonstrate the presence and
location of in vivo bound substances such as immunoglobulins and complement.
FIG. 2
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The direct immunofluorescent test.
Fluoroscein-labelled anti-human immunoglobulin, etc., is added to a suitably pre-
pared tissue section and the specimen is examined under blue light. If the antd-
human immunoglobulin has been 'fixed'. its presence will be identified by
fluorescence.
Serum samples are examined by the indirect immunofluorescent technique
(Fig. 3), the purpose of this test being the detection of circulating antibodies.
To perform the test, the patient's serum is added to a variety of substrates
(tissues); if the appropriate antibody is present it will 'fix' to its corresponding
antigen in the substrate. Fluoroscein-labelled anti-human immunoglobulin is
then added and the section is examined under blue light.
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The indirect immunofluorescent test.
DISEASES STUDIED
(TABLE 1)
Immunofluorescent findings in the more commonly investigated skin diseases.
Diseave Skin Serum
PEMPHIGUS (variants.) Intercellular staining Anti-intercellular substance
of squamous epithelium antibody
BULLOUS PEMPHIGOID Linear basement Anti-basement membrane
membrane staining antibody
DERMATITIS IgA in dermal papillae ? anti-reticulin antibody
HERPETIFORMIS
BENIGN MUCOUS Linear basement Low titre anti-basement
MEMBRANE membrane staining membrane antibody
PEMPHIGOID
SYSTEMIC LUPUS Granular staining at Anti-nuclear factor, etc.
ERYTHEMATOSUS basement membrane
(lesion and normal skin)
DISCOID LUPUS Granular staining at May contain anti-nuclear
ERYTHEMATOSUS basement membrane fac or
(lesion only)
198SYSIEMIC SCLEROSIS
MIXED CONNECTIVE
TISSUE DISEASE
Negative
IgM, rarely IgG at
basement membrane or
within blood vessels
Anti-nuclear factor
Anti-ribonucleoprotein,
antibody to 'extractable'
nuclear antigen
VASCULMIiDES May find immunoglobulin
and complement
FIGS. 4 to 7
FIG. 4 (Top left). Pemphigus vulgaris. 'Fish-net' staining around prickle cells x 250.
FIG. 5 (Top right). Bullous pemphigoid. Linear staining at basement membrne region x
100.
FIG. 6 (Lower left). Dermatitis herpetiformis. Positive staining in the dermal papillae x 100.
FIG. 7 (Lower right). Systemic lupus erythematosus. Positive graniular staining at basement
membrane region x 250.
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NegativePemphigus
Pemphigus vulgaris has long been known to be an immunologically mediated
disease (Beutner and Jordon, 1964). Immunoglobulins and complement are found
in the inter-cellular region of the squamous epithelium (Fig. 4). The much rarer
pemphigus erythematosus is characterised by immunoglobulins and complement
in a granular distribution at the epidermo-dermal junction in addition to the
changes mentioned above. Pemphigus foliaceus shows features similar to pemphi-
gus vulgaris.
Examination of the serum from a patient with pemphigus can virtually always
be shown to contain an antibody (usually IgG), which reacts with the intercellular
region of squamous epithelium. Circulating antibodies can sometimes be difficult
to detect and repeat samples may be necessary. A source of possible confusion
may arise with the pemphigus-like antibodies that are known to develop on
occasion in people with severe burns (Thivolet and Beyvin, 1968).
The presence and titre of anti-intercellular antibody have been shown to be of
prognostic value in patients with pemphigus (Beutner, Chorzelski and Jordon,
1970). An individual change in titre is not sufficient for adjustment of steroid
dosage, but an increasing titre is certainly suggestive of impending relapse and,
thus, possibly an indication for altering treatment dosages. Repeat tests should
be performed perhaps weekly whilst the patient is in relapse, and every three or
six months when in remission.
Bullous Pemphigoid
This interesting disease can be a problem both clinically and histologically. It
is, therefore, fortunate that pemphigoid is characterised by the presence of a
specific (as far as is known) antibody (Fig. 5) active against the basement mem-
brane region of squamous epithelium (Beutner, Jordon and Chorzelski, 1968).
Unfortunately, there does not seem to be much correlation between titres of
basement membrane antibody and the severity of the disease process.
Benign Mucous Membrane Pemphigoid
Recent studies (Hudson and Black, 1975) have shown that this disease has
features similar to bullous pemphigoid. IgG and complement (more rarely IgA)
are found at the basement membrane region of the biopsy. Although usually in
low titre, circulating antibodies have been detected against the basement mem-
brane zone.
Dermatitis Herpetiformis
Immunofluorescent examination of the biopsy typically shows the presence of
granular IgA in the dermal papillae (Fig. 6). Complement may also be demon-
strated in a similar location. Rarely they may be found at the basement mem-
brane region, and are occasionally linear. It is to be emphasised that the IgA
deposits may be patchy in distribution and, therefore, repeat biopsies occasionally
are necessary to establish the diagnosis.
200Examination of the serum in patients with dermatitis herpetiformis may reveal
a variety of antibodies. These include anti-reticulin antibody, anti-gastric parietal
cell antibody, anti-nuclear factor and thyroid microsomal antibody. Of these,
anti-reticulin antibody is of most significance.
Systemic and Discoid Lupus Erythematosus
Immunological investigations are obviously of great importance in both the
above conditions.
Examination of a skin biopsy can be of diagnostic value in both discoid and
systemic lupus. It shows granular deposits of immunoglobulins (IgG and/or
IgM) and complement at the epidermodermal junction (Fig. 7). This is of
particular importance in the diagnosis of systemic lupus, in that these deposits
are found in clinically normal (sun-exposed) skin as well as in the lesion itself.
Cases of so-called transitional lupus may show deposits in normal skin. It is
worthwhile remembering that false negative results can occur in patients on
steroid therapy. Some workers (Dantzig, Mauro, Rayhanzadeh and Rudofsky,
1975) have shown that there is a high correlation between positive cutaneous
immunofluorescence and the more severe forms of lupus nephritis.
Scleroderma
Examination of skin biopsies from patients with scleroderma and morphoea
are disappointingly negative. Examination of the serum in cases of scleroderma
frequently reveals an anti-nuclear antibody, often of the speckled or nucleolar
type. In morphoea the serum is usually free from such antibodies.
However, in the less common mixed connective tissue disease (mesenchymal,
inflammatory scleroderma) recent studies (Winkelmann, Carapeto and Jordon,
1977) have shown that immunofluorescence may have some part to play in
diagnosis. Immunoglobulins (IgM, rarely IgG) and complement were described
at the basement membrane or within blood vessels. Serological investigation is
said to reval the presence of antibodies to ribonucleoprotein and 'extractable'
nuclear antigen.
Vasculitides
A variety of primary vascular inflammatory diseases exist and many of these
involve cutaneous vessels, e.g. allergic vasculitis, polyarteritis nodosa. If immuno-
fluorescent tests are to be performed, the biopsy should be taken from an early
lesion. Direct immunofluorescence may reval immunoglobulin and complement
in and around blood vessels. However, interpretation of these biopsies is often
exceedingly difficult.
RESULTS
During the period May 1975 to May 1977 specimens were received from 170
patients. These included 337 skin biopsies and 379 serum samples. The sub-
mitted material included a wide range of conditions (Table 2).
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Range of diseases
Disease No. of cases
Dermatitis herpetiformis 34
Bullous phemphigoid 15
Pemphigus (variants) 7
Cicatricial pemphigoid 2
Lupus erythematosus (discoid & systemic) 11
Vasculitis 10
Lichen planus 2
Psoriasis 2
Herpes gestationis 2
Scleroderma 2
Subcorneal pustular dermatosis 2
Dermatitis (variants) 13
Purpura 3
Pruritis 5
Hailey-Hailey disease 1
Total
investigated.
Disease No. of
Urticaria
Darier's disease
Erythema elevatum diutinum
Jessner's lymphocytic infiltrate
Acne rosacea
Photosensitivity
Necrobiosis lipoidica diabeticorum
Bechet's syndrome
Familial annular erythema
Lupus vulgaris
Balanitis
Folliculitis
Pityriasis rosea
Verruca vulgaris
Untraceable
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Dermatitis herpetiformis was the most commonly encountered disease, material
being examined from a total of 34 patients (Tables 3 and 4). Skin biopsies were
shown to contain IgA with or without complement in the dermal papillae, or
less commonly along the basement membrane in 23 (67%) patients. Examination
(TABLE 3)
No. of cases
11
7
2
3
11
34
Dermatitis herpetiformis skin biopsies Results.
Direct immunofluorescence of skin biopsy
IgA in DP'
IgA + C" in DP
Granular IgA at BMt
Linear IgA at BM
Negative
Total
*DP dermal papillae; * *C complement
tBM basement membrane
(TABLE 4)
Dermatitis Herpetiformis Serum Results
No. of cases
4
4
1
1
24
34
Indirect immunofluorescent examination
Anti-reticulin antibody
Anti-gastric parietal cell antibody
Anti-nuclear factor
Anti-intercellular substance antibody
No antibody
Total
202
cases
7
1
1
1
1
2
1
1
1
1
1
1
1
1
40of the serum disclosed a variety of antibodies, including anti-reticulin and anti-
gastric parietal cell antibodies.
Speciments were received from 15 patients with bullous pemphigoid (Table 5).
In all cases in which immunofluorescent studies were performed on skin biopsies,
immunoglobulins and/or complement were found deposited in a linear fashion
(TABLE 5)
No. of cases
1
6
1
1
1
5
15
Pemphigoid - Skin Biopsies Results
Direct immunofluorescence of skin biopsy
Linear IgG at BM
Linear IgG + C at BM
Linear IgG . IgM + C at BM
Linear IgM at BM
Linear C at BM
Not performed
Total
along the basement membrane. The serum in all cases contained an anti-
basement membrane antibody of the IgG sub-class.
Oral mucosa and serum were examined from two patients with cicatricial
pemphigoid. In each case IgG and complement were demonstrated as a linear
deposition along the basement membrane of the mucosa. Antibodies were not
detected in their sera.
Pemphigus is an exceedingly rare disease and we were fortunate in being
able to study seven cases. Of these, six patients had skin biopsies performed
(TABLE 6)
No. of cases
3
1
1
1
7
Pemphigus - Skin Biopsies Results
Direct immunofluorescent of skin biopsy
IgG in ICRtt
IgA in ICR
IgG + C in ICR
IgG + IgM in ICR
Not examined
Total
tt ICR - intercellular region
(Table 6). Examination of the serum in all patients revealed an antibody (IgG
in six cases, IgA in one) of the pemphigus type.
We investigated specimens from eleven patients with lupus erythematosus
(Table 7). Of these, nine were of the discoid type and two of the systemic type.
In all cases immunoglobulins and/or complement were detected as a granular
203No. of cases
2
1
1
2
1
3
1
2
13
(TABLE 7)
Lupus Erythematosus - Skin Biopsies Results
Direct immunofluorescence of skin biopsy
Granular IgG . C at BM
Granular IgG + IgA . C at BM
Granular C at BM
Granular IgG I IgM + C at BM
Granular IggG + IgM at BM
Granular IgM at BM
Granular IgM . C at BM
Negative (uninvolved skin)
Total
deposit at the basement of the membrane region of the skin. Skin biopsies from
unaffected skin in the two patients suspected to be suffering from systemic lupus
erythematosus were negative.
Skin biopsies from ten patients suspected of suffering from a vasculitis were
examined (Table 8). In eight of these immunoglobulins and/or complement were
detected outlining the dermal blood vessels.
(TABLE 8)
No. of cases
1
1
3
1
1
2
10
§BV - blood vessels
Vasculitis - Skin Biopsies Results
Direct immunofluorescence of skin biopsy
IgA + C outlining BV§
IgA outlining BV
C outlining BV
IgM + C outlining BV
IgG, IgM + C outlining BV
IgG + C outlining BV
Negative
Total
Two patients sufiered from herpes gestationis. Skin biopsies from both were
examined by the direct immunofluorescent technique. In both, IgG and comple-
ment were detected as a granular, almost linear deposition along the basement
membrane region. Examination of the sera failed to reveal any antibodies.
Immunofluorescent examination of the skin from two patients with lichen
planus was performed. Characteristic fluorescent bodies were identified in the
papillary dermis on treating the sections with fluoroscein-labelled anti-IgG,
anti-IgM and anti-complement.
Significant fluorescent findings were not found in any of the other cases.
204CONCLUSIONS
Our experience over a two year period has confirmed the value of immuno-
fluorescence in diagnostic dermatology. Thus, immunofluorescence may establish
a diagnosis in cases where there is a doubt,, and can on occasion be of value in
assessing treatment regimes. There are, however, several points which must be
emphasised.Firstly, the biopsy must be taken from the correct site (Fig 1),
otherwise the possibility of false negative results arise. Secondly, an adequate
clinical history with information of current treatment is essential, since an
increasing number of drugs are being associated with a variety of auto-antibodies,
e.g. pemphigus-type antibodies in patients taking rifampicin (Gange et al., 1976).
Thirdly, in patients suspected to be suffering from dermatitis herpetiformis there
is, unfortunately, a known (albiet low) tendency for a false negative result. The
laboratory, therefore, must examine diligently a large number of sections in
order to detect the IgA deposits. On occasion a repeat biopsy will be necessary.
To date we have not, to our knowledge, experienced either false positive or
false negative results in either pemphigus or pemphigoid cases.
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